Pharma

Your Article Summary

See Latest Articles

European approvals for Levocetirizine
Synthon, 05/26/09

Levocetirizine is the active ingredient of UCB's brand product Xyzal. Xyzal is indicated for the treatment of chronic idiopathic urticaria and for relief of symptoms associated with allergic rhinitis. European sales of Xyzal in 2008 were 155 million Euros based on IMS Midas data.

Today in Drug/Product Approvals...keeping you current

Receive free subspecialty "5-minute updates" via email

FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09

Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09

Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09

See All of Drug/Product Approvals